159
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Reliability of 51Cr-EDTA plasma and urinary clearance as a measure of residual renal function in dialysis patients

, , &
Pages 663-669 | Received 24 Jun 2011, Accepted 28 Jul 2011, Published online: 13 Oct 2011

References

  • de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, Collart F, Finne P, Heaf JG, De Meester J, Wetzels JFM, Rosendaal FR, Dekker FW. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009;302:1782–9.
  • Wang AY, Lai KN. The importance of residual renal function in dialysis patients. Kidney Int 2006;69:1726–32.
  • Perl J, Bargman JM. The importance of residual kidney function for patients on dialysis: a critical review. Am J Kidney Dis. 2009;53:1068–81.
  • Rehling M, Moller ML, Thamdrup B, Lund JO, Trap-Jensen J. Simultaneous measurement of renal clearance and plasma clearance of 99mTc-labelled diethylenetriaminepenta-acetate, 51Cr-labelled ethylenediaminetetra-acetate and inulin in man. Clin Sci (Lond) 1984;66:613–9.
  • Brochner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972;30:271–4.
  • Kamper AL, Nielsen SL. 51Cr-EDTA plasma clearance in severe renal failure determined by one plasma sample. Scand J Clin Lab Invest 1989;49:555–9.
  • Brochner-Mortensen J, Rodbro P. Optimum time of blood sampling for determination of glomerular filtration rate by single-injection [51Cr]EDTA plasma clearance. Scand J Clin Lab Invest 1976;36:795–800.
  • Du Bois D, Du Bois EF. Clinical calorimetry: tenth paper: a formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916;17:863–71.
  • Bland JM, Altman DG. Measurement error proportional to the mean. BMJ 1996;313:106.
  • Euser AM, Dekker FW, le Cessie S. A practical approach to Bland-Altman plots and variation coefficients for log transformed variables. J Clin Epidemiol 2008;61:978–82.
  • Shemin D, Bostom AG, Laliberty P, Dworkin LD. Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis 2001;38:85–90.
  • Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD )-2. Am J Kidney Dis 2003;41:1293–302.
  • Brochner-Mortensen J, Freund LG. Reliability of routine clearance methods for assessment of glomerular filtration rate in advanced renal insufficiency. Scand J Clin Lab Invest 1981;41:91–7.
  • Henriksen JH, Brochner-Mortensen J, Malchow-Moller A, Schlichting P. Over-estimation of glomerular filtration rate by single injection [51Cr]EDTA plasma clearance determination in patients with ascites. Scand J Clin Lab Invest 1980;40:279–84.
  • Mortensen JB, Rodbro P. Comparison between total and renal plasma clearance of [51Cr] EDTA. Scand J Clin Lab Invest 1976;36:247–9.
  • Rehling M, Nielsen BV, Pedersen EB, Nielsen LE, Hansen HE, Bacher T. Renal and extrarenal clearance of 99mTc-MAG3: a comparison with 125I-OIH and 51Cr-EDTA in patients representing all levels of glomerular filtration rate. Eur J Nucl Med 1995;22:1379–84.
  • Effersoe H, Rosenkilde P, Groth S, Jensen LI, Golman K. Measurement of renal function with iohexol. A comparison of iohexol, 99mTc-DTPA, and 51Cr-EDTA clearance. Invest Radiol 1990;25:778–82.
  • Swan SK, Halstenson CE, Kasiske BL, Collins AJ. Determination of residual renal function with iohexol clearance in hemodialysis patients. Kidney Int 1996;49:232–5.
  • Sterner G, Frennby B, Mansson S, Ohlsson A, Prutz KG, Almen T. Assessing residual renal function and efficiency of hemodialysis – an application for urographic contrast media. Nephron 2000;85:324–33.
  • van Olden RW, van Acker BA, Koomen GC, Krediet RT, Arisz L. Time course of inulin and creatinine clearance in the interval between two haemodialysis treatments. Nephrol Dial Transplant 1995;10:2274–80.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.